BTC$60,708.00+1.19%
ETH$1,603.45+1.75%
USDT$0.9984-0.02%
BNB$565.47-0.15%
USDC$0.99970.00%
XRP$1.07+2.28%
SOL$72.64+0.01%
TRX$0.3206+0.45%
FIGR_HELOC$1.03-0.38%
HYPE$64.15-1.43%
DOGE$0.0761+1.05%
RAIN$0.0157-0.25%
USDS$0.9994-0.01%
LEO$9.37+0.95%
ZEC$410.76-2.78%
XLM$0.1774-0.72%
BTC$60,708.00+1.19%
ETH$1,603.45+1.75%
USDT$0.9984-0.02%
BNB$565.47-0.15%
USDC$0.99970.00%
XRP$1.07+2.28%
SOL$72.64+0.01%
TRX$0.3206+0.45%
FIGR_HELOC$1.03-0.38%
HYPE$64.15-1.43%
DOGE$0.0761+1.05%
RAIN$0.0157-0.25%
USDS$0.9994-0.01%
LEO$9.37+0.95%
ZEC$410.76-2.78%
XLM$0.1774-0.72%
Thermo Fisher Scientific beat Q4 expectations with EPS of $6.57 on revenue of $12.21 billion and shared its outlook for 2026.
Thermo Fisher Scientific reported 5% revenue growth in Q3 2025 with adjusted EPS of $5.79, beating expectations and reinforcing its positive long-term outlook.
Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing expectations.
Thermo Fisher Scientific Inc. (NYSE: TMO) reported a revenue of $10.60 billion in the third quarter of 2024.
Thermo Fisher Scientific reported $10.54 billion in revenue for Q2 2024.
Thermo Fisher Scientific Inc. has showcased its financial strength in the first quarter of 2024, with a slight revenue decline but commendable growth in GAAP diluted…
Thermo Fisher Scientific Inc. (NYSE: TMO) has reported a strong fourth quarter for 2023, surpassing financial expectations with a slight increase in EPS and higher-than-expected revenue.